Clinical Neuropharmacology · 2011 · 54 citations · 27 references
MedicineNeurologyNeuroscienceMovement DisordersNeurodegenerationNeuromuscular DisordersGait DisordersMotor DisordersMotor Neuron DiseasesMotor Neuron DisordersParkinson DiseaseParkinsonian DisordersClinical Diagnosis Of ParkinsonismFreezing Of Gait AssessmentMotor Symptom ProgressionParkinson's Disease Pharmacotherapy
The causes and mechanism behind motor complications in Parkinson disease (PD) are still a subject of debate. Several factors including age at onset, evolution in years, and initial medication can influence the onset and severity of motor complications in PD.We studied patients with recent diagnosis of PD who were followed up prospectively for 10 years. Analysis included the progression of these patients, as measured by the Unified Parkinson Disease Rating Scale scores and the presence of motor complications (motors fluctuations, dyskinesias, and gait freezing) over time. The patient group was studied as a whole and by subgroups classified according to age at onset, initial treatment, and sex.By the end of the first decade, most patients exhibited dyskinesias (91%), motor fluctuations (62%), and freezing of gait (68%). An association was found between several patients' characteristics and presence of motor complications by 5 years, though not after 10 years of follow up. The apparition of motor fluctuations was mainly related to initial treatment (odds ratio [OR], 3.87). The development of dyskinesias was linked to initial treatment (OR, 8.31), age at onset (OR, 0.90), and sex (OR, 12.87).
27
Levodopa and the Progression of Parkinson's Disease
New England Journal of Medicine · 2004 · 1.8K citations · Full text
Olivier Rascol, David J. Brooks, Amos D. Korczyn et al. · New England Journal of Medicine · 2000 · 1.5K citations · Full text
Medicine, Neurology, Pharmacotherapy +11
What features improve the accuracy of clinical diagnosis in Parkinson's disease
Andrew Hughes, Yoav Ben‐Shlomo, Susan E. Daniel et al. · Neurology · 1992 · 1.3K citations
Pramipexole vs Levodopa as initial treatment for Parkinson disease: A randomized controlled trial
Robert G. Holloway, Ira Shoulson, Karl Kieburtz et al. · JAMA · 2000 · 802 citations
Medicine, Neurology, Pharmacotherapy +12
Pramipexole vs Levodopa as Initial Treatment for Parkinson Disease
Parkinson Study Group · JAMA · 2000 · 764 citations